The New England Journal of Medicine has published a clinical decision piece on how doctors should approach initial screening for bowel cancer, adding to ongoing debate about the best methods for catching the disease early.
The journal posted the piece under its Clinical Decisions series, tagging it to the fields of gastroenterology (the study of the digestive system) and oncology (cancer medicine). Bowel cancer — also called colorectal cancer — develops in the colon or rectum and is one of the most common cancers diagnosed in the UK, according to the NHS.
Screening aims to find the disease before symptoms appear, when treatment is most likely to succeed.
The NHS offers bowel cancer screening to everyone aged 50 to 74 in England through a home testing kit, known as a faecal immunochemical test (FIT), which checks a small stool sample for traces of blood. People in that age group are sent a kit automatically and do not need to request one. Those outside the screening age who have symptoms — such as blood in their stools, a persistent change in bowel habits, or unexplained weight loss — should contact their GP rather than wait for a routine invite.
Meanwhile, the New England Journal of Medicine’s focus on initial screening decisions reflects an active area of medical discussion: which tests to offer first, to whom, and at what age. The journal did not release the full clinical findings in the tweet itself, so the specific recommendations or case details have not been verified from this source alone.
—
Getting Screened
- NHS bowel cancer screening kits are sent automatically to people aged 50 to 74 registered with a GP in England
- If you have not received a kit and are in that age group, contact your GP surgery
- Anyone with bowel symptoms at any age should speak to their GP — do not wait for a screening invitation
- Call NHS 111 if you are unsure whether your symptoms need urgent attention, or 999 in an emergency
Source: @NEJM (clinical decision piece); NHS England (screening programme details)